Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

• Hanno Maximilian Witte,
• Hanno Maximilian Witte,
• Hanno Maximilian Witte,
• Axel Künstner,
• Axel Künstner,
• Emil Chteinberg,
• Francesco Piazza,
• Gaël Roué,
• Niklas Gebauer,
• Niklas Gebauer

Affiliations

Hanno Maximilian Witte

Department of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Ulm, Germany

Hanno Maximilian Witte

Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany

Hanno Maximilian Witte

University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany

Axel Künstner

University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany

Axel Künstner

Medical Systems Biology Group, University of Lübeck, Lübeck, Germany

Emil Chteinberg

Institute of Human Genetics Ulm University and Ulm University Medical Center, Ulm, Germany

Francesco Piazza

Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova and Myeloma and Lymphoma Pathobiology Laboratory, Veneto Istituto of Molecular Medicine, Padova, Italy

Gaël Roué

Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain

Niklas Gebauer

Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany

Niklas Gebauer

University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany